Progressive hemispheric shrinking in hemimegalencephaly: A possible role for seizure-related neuronal loss

Developmental Medicine and Child Neurology

Volumn 50, Issue 7, 2008, Pages 553-557

  Becherini, Francesca ^a   Pisano, Tiziana ^b   Castagna, Maura ^a   Iannelli, Aldo ^c   Guerrini, Renzo ^d  

^a UNIVERSITY OF PISA   (Italy)

^b DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

APOPTOSIS; ARTICLE; BRAIN ATROPHY; BRAIN DISEASE; CASE REPORT; CELL COUNT; CELL STRUCTURE; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; HEMIMEGALENCEPHALY; HEMISPHERE; HEMISPHERECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACTABLE EPILEPSY; NERVE CELL; NERVE CELL NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SEIZURE;

CASPASE 3; CELL DEATH; CHILD; ELECTROENCEPHALOGRAPHY; FEMALE; FUNCTIONAL LATERALITY; HEMISPHERECTOMY; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROAXONAL DYSTROPHIES; SEIZURES;

EID: 47149096150     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2008.03003.x     Document Type: Article

References (16)

1. Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. A developmental and genetic classification for malformations of cortical development. Neurology 2005; 65: 1873-87.
2. Kiernan C, Jones M. Behaviour assessment battery: Assessment of cognitive, communicative and self-help skills of severely handicapped children. Windsor: NFER Nelson, 1982.
3. Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behaviour Scales. Circle Pines, MN: American Guidance Service, 1984.
4. Griffiths R. The abilities of young children. London: University of London Press, 1970.
5. Gown AM, Willingham MC. Improved detection of apoptotic cells in archival paraffin sections: Immunohistochemistry using antibodies to cleaved Caspase-3. J Histochem Cytochem 2002; 50: 449-54.
6. Wolpert SM, Cohen A, Libenson MH. Hemimegalencephaly: A longitudinal MR study. AJNR Am J Neuroradiol 1993; 15: 1479-82.
7. Sakuma H, Ohsuke I, Masayuki S. Longitudianl MR findings in a patient with hemimegalencephaly associated with tuberous sclerosis. Brain Dev 2005; 27: 458-61.
8. Parmar H, Patkar D, Shah J, Patankar T. Hemimegalencephaly with tuberous sclerosis: A longitudibal imaging study. Australas Radiol 2003; 47: 438-42.
9. Robain O, Floquet C, Heldt N, Rozenberg F. Hemimegalencephaly: A clinicopathological study of four cases. Neuropathol Appl Neurobiol 1988; 14: 125-35.
10. Thom M. Epilepsy Part I: Hemimegalencephaly. In: Golden JA, Harding B, editors. Developmental Neuropathology. Basel: ISN Neuropath Press, 2004: 67-72.
11. Henshall DC, Clark RS, Adelson PD, Chen M, Watkins SC, Simon RP. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 2000; 55: 250-57.
12. Tanaka M, Momoi T, Marunouchi T. In situ detection of activated caspase-3 in apoptotic granule neurons in the developing cerebellum in slice cultures and in vivo. Brain Res Dev Brain Res 2000; 121: 223-28.
13. Ben-Ari Y, Holmes GL. Effects of seizures on developmental processes in the immature brain. Lancet Neurol 2006; 5: 1055-63.
14. Hossain MA. Molecular mediators of hypoxic-ischemic injury and implications for epilepsy in the developing brain. Epilepsy Behav 2005; 7: 204-13.
15. Guerrini R, Marini C. Genetic malformations of cortical development. Exp Brain Res 2006; 173: 322-33.
16. Sato N, Yagishita A, Oba H, et al. Hemimegalencephaly: A study of abnormalities occurring outside the involved hemisphere. AJNR Am J Neuroradiol 2007; 28: 678-82.